Shire Sues Impax Again Over New Adderall ANDAs
U.K. drug maker Shire Pharmaceuticals has filed a second lawsuit against U.S. generics maker Impax Labs based on an abbreviated new drug application for another dosage of best-selling attention-deficit drug Adderall...To view the full article, register now.
Already a subscriber? Click here to view full article